ABSTRACT Serum from an individual with occupational asthma from nickel sulphate inhalation was shown by ammonium sulphate (Farr) and anti-IgG coprecipitation tests to contain antibodies which bind 63Ni2+. This binding was absent from 30 control sera. Ligand competition studies with serum and plasma from the propositus and controls are described, and include serial additions of HSA, L-histidine, EDTA, and the tripeptide gly-gly-L-his. The results, like those from metal ion blocking experiments, clearly showed that the formation of the reactive antigenic determinant depends on the selective binding of Ni2+ at the native Cu2+/Ni2+ transport site of HSA. Corroborating evidence is derived from the similar dependence on pH of the Ni2+-HSA formation and the ammonium sulphate 63Ni2+ coprecipitation reactions.
and the ammonium sulphate 63Ni2+ coprecipitation reactions.
In part I we applied principles of inorganic biochemistry in a study of the antigenic determinant of antibody with Ni2+-related specificity. ' The serum of worker SB, who had occupational asthma from nickel sulphate inhalation, had previously been shown to react in a Ni-HSA radioallergosorbant test for antibodies of the IgE class.2 The presence of antibody with nickel related specificity was confirmed by the selective precipitation of 63Ni2+ in an ammonium sulphate induced coprecipitation reaction.' Preincubation of the labelled nickel with human serum albumin (HSA) increased the discrimination of this coprecipitation test. Furthermore, metal ion blocking experiments indicated strongly that the antigenic determinant depended on the combination of Ni2+ with HSA at the specific copper-nickel transport site located at its N-terminus. In the present paper new evidence is presented for the presence of antibody with Ni2+ recognition in SB's serum (plasma) , and the specificity of the Ni2+-HSA requirement is documented and explored further.
To augment the characterisation of the sensitising role and a consequent requirement of HSA in detection of antibody by the ammonium sulphate coprecipitation test, an HSA dose response curve is reported for the allergic individual (SB) and for non-allergic control plasma samples. A comparison is also made of the pH dependence of formation of the Ni2+-HSA complex with that of the coprecipitation reaction. Moreover, ligand competition is explored as a probe since some ligands are known to compete effectively at physiological pH values with HSA for Ni2+. Sarkar and co-workers have shown that L-histidine and tripeptides mimicking the primary binding mode of HSA form complexes of comparable stabilities to HSA with Ni2+ and Cu2+ 3-' As might be expected from its high affinity for the nickel ion,8 EDTA has been shown to remove 90% of Ni2+ from HSA when both reagents were at comparable concentrations.9 Ligand inhibition of 63Ni2+ coprecipitation might therefore be expected for L-histidine, gly-gly-L-his, and EDTA, and should provide another avenue for testing the hypothesis concerning the central role of the Ni2+-HSA complex. To examine the effect of lipid-free HSA, 20 u1l freshly prepared solutions in concentrations of 1.5 x 10-4 M (10 mg/ml), 0X50 x 10-4 M, 1*5 x 10-1 M, 0-50 x 10-5 M, and 1 5 x 10-6 M in distilled H20 or H20 control were added to 100 ,ul 63Ni2+ in borate saline buffer (pH 8.3) and incubated for two hours.
The mixture was then added to 100 pul plasma for overnight incubation. The effect of EDTA was examined by adding 10 ,ul EDTA (10-' M, 3 x 10-2 M, 10-2 M, and 10-3 M solutions in borate buffer) or borate buffer control to 100 ,ul serum and incubating for 2 h, followed by the addition of 100 ,ul labelled Ni2+ in buffer and overnight incubation. To determine the effect of L-histidine, 20 p.l L-histidine (10-' M, 3 x 10-2 M, 10-2 M, or 10-3 M in borate buffer, pH 9.3) or buffer control alone was incubated with 100 p.l 63Ni2+ in borate saline for 2 h, followed by the usual addition to 100 p.l serum for overnight incubation at 4°C. For studies with the tripeptide gly-gly-L-his, 100 p.l of 63Ni2+ in borate buffer was incubated for 2 h at ambient temperature with 20 p.l of freshly prepared HSA (1.5 x 10-1 M) or distilled water and 20 ,ul of freshly prepared pep-Nieboer, Evans, and Dolovich tide (3.3 x 10-3 M, 3.3 x 10-4 M, or 3-3 x 10-5 M) or distilled water. Subsequently 100 ,u1 of plasma was added followed by overnight incubation at 4°C before the coprecipitation reaction.
METAL ION STUDIES
The effect of nickel, copper, cobalt, manganese, and chromium salts was examined in tests performed with SB and control plasma specimens by the addition of the appropriate metal ion in 20 ,u1 amounts to 100 ,ul of plasma followed by overnight incubation at room temperature. There was then the addition of a mixture of 100 ,ul 63Ni and 20 ,ul of HSA (1-5 x 10-5 M), followed by another overnight incubation at 4°C, and the ammonium sulphate coprecipitation reaction. The molar concentration of non-labelled salt required to produce a 50% inhibition (IC,,) of 63Ni coprecipitation for SB plasma was derived from a semilog plot of the observed counts corrected for background. The latter was taken as the counts for non-antibody control sera tested in the same experiment (see for example, fig 2A, part I). ' The effect of nickel and copper sulphate on ampicillin coprecipitation from an antibody containing serum was examined in the manner just described except for two modifications: (1) the ampicillin-'25I-HSA was the labelled reagent rather than 63Ni2+/HSA and (2) !~1000 .
-I-/r 0 4 Nieboer, Evans, and Dolovich increase in coprecipitation with control plasma specimens (fig 4) . The preincubation of the peptide alone with 63Ni2+ had no effect. The influence of preincubating sera with disodium EDTA, a substance which chelates Ni2+, is illustrated in fig 5. At the lowest concentration, there was an increase in 63Ni2+ coprecipitation, particularly with SB plasma. At the largest concentrations of EDTA, the coprecipitation of 63Ni2+ was virtually abolished. By contrast (fig 5) , disodium EDTA did not affect the coprecipitation of the protein antigen (labelled HSA) with the corresponding antibody (rabbit anti-HSA).
L-histidine when preincubated with 63Ni2+ at concentrations in molar excess of the added label (total Ni2+, 3 x 10-8 M) produced results resembling those of EDTA (fig 6) . At the highest concentrations, this amino acid reduced the 63Ni2+ coprecipitation with both SB serum and control sera but did not affect the ammonium sulphate coprecipitation test involving the organic antigen, ampicillin, in reaction with antibody to ampicillin.
The concentrations indicated on the abscissae of figs 1 and 3-6 refer to the sample mixtures incubated overnight at 4°C (usually 0-2 ml total volume), and non-addition is denoted by zero on the concentration scale. 
METAL ION EFFECTS
The blocking effects observed for SB plasma or serum of non-labelled Ni2+, Cu2+, and Co2+ were not evident for control plasma specimens. Presumably this blocking is due to a competition for binding sites which must be considered to be antibody related due to the exclusive effect on SB plasma. The absence of any effect due to metal ions on labelled antigen binding in the coprecipitation of ampicillin from serum with antiampicillin antibodies (fig 1) attests to the specificity of the inhibitory effect observed for SB samples. As summarised previously,' Ni2+ and Cu2+ have the highest affinity for the copper transport site of HSA. Co2+ has a lower binding affinity, while Zn2+, Mn2 , and Cr3+ cations do not bind there at all. At least qualitatively, the potency of the inhibitory effect would appear to parallel the binding capacity of the ions at this specific site, since the IC,, values reported in table 2 are in the ratio of 1 (Ni2+):40(Cu2+):4000(Co2+).
Since, however, the NiHSA complex has been reported to be considerably less stable (with a formation constant log KNiL = 9-6, at 6°C and u = 0-16)' than the CuHSA species (log KCuL = 16-2, at 6°C and A = 0X16),3 thermodynamic arguments might have predicted that Cu2+ would be more effective than non-labelled Ni2+ in displacing 63Ni2+ in the coprecipitation test. Since this did not occur, it may be concluded that the HSA-Ni-antibody interaction is highly specific. The basis for this selectivity is not clear. Perhaps special structural features of NiHSA not present in CuHSA are responsible for the implied unusual stability of the ternary complex between Ni2+, HSA, and antibody.
LIGAND COMPETITION STUDIES
An analysis of the data reported in fig 3 indicated that the discrimination between SB and control plasma samples was maximum for added HSA concentrations between 10-6_107 M HSA. (For comparison, the total concentration of Ni2+ in the incubation medium due to the concomitant addition of label was 3 x 10-8 M; and the HSA derived from plasma was -2 x 10-4 M.) The nickel-HSA prein-cubation step appears to assure the preformation of 63Ni2+HSA, presumably making it available for the formation of the ternary HSA-63Ni2+-antibody complex on addition of SB serum or plasma. Corroborating evidence for this interpretation may be gleaned from the data in fig 4. Although the tripeptide gly-gly-L-his itself did not induce any enhancement, it abolished that initiated by HSA when present simultaneously with it in the preincubation step. In this experiment the added concentration (referred to the incubation medium) of HSA was 1-3 x 10-6 M and of Ni2+ (as the label) 3 x 10-8 M; these concentrations are roughly one half of what occurred in the preincubation medium. Since the tripeptide and HSA form complexes of similar strength (with formation constants of 10 log units),7 the 63Ni2+ becomes progressively more associated with the peptide as its concentration increases to a maximum of 2*8 x 10-s M (referred to the incubation medium).
Data from rabbit anti-HSA serum ( fig 5) and ampicillin allergic serum (fig 6) illustrate clearly that EDTA and L-histidine do not inferfere in a fundamental manner with the ammonium sulphate antigen-antibody coprecipitation test. Consequently, the alterations induced in the 63Ni2+ coprecipitation studies are correctly assigned to ligand/Ni2+ competition effects. It is evident from the data in figs 5 and 6 that high concentrations of EDTA and L-histidine in the incubation medium reduces the coprecipitation of 63Ni2+ to background levels. All of the label would thus appear to be associated with the added ligand in both SB and control samples. The concentration required to accomplish this for L-histidine was twice as large (2.7 x 10-3 M) than required for EDTA (1-4 x 10-s M). This is consistent with their relative complex stabilities (log KNL(his) = 8-6; log KNiL, (his) = 15-6; log KNiL (EDTA) = 18-6).78
The relatively large increase in 63Ni2+ coprecipitation for SB serum with EDTA < 10-3 M is interpreted to result from a reduction in the availability of non-labelled Ni2+ present as natural background contamination. In addition to the Ni2+, this ligand would be bound to other cations in the serum such as Ca2+, Mg2+, Zn2+, and Cu2+, and therefore was not present in large excess. As may be deduced from the average IC,O value of -10-6 M for Ni2+ salts in table 2, concentrations of added non-labelled Ni2+ as low as 10-7 M had measurable depressive effects on the coprecipitation test. ' Background levels of 10-7 M (-6 ,ug/l) due to random contamination are common.'3 '4 Presumably a larger fraction of the 63Ni2+ added subsequently is available for incorporation into the ternary HSA-Ni2+-antibody complex.
And finally, the noticeable enhancement in 63Ni2+ counts for control sera due to low levels of L-histidine in the incubation medium (8.3 x 10-5 M) suggests that this ligand does not block the availability of 63Ni2+ for non-specific binding in the coprecipitation reaction. Exchange phenomena involving Cu2+, L-histidine, and HSA have been documented.3 '5 Furthermore, Ni2+ in serum is known to be distributed and exchanged between the binary complexes Ni-HSA, Ni(his), and Ni(his)2, as well as with the ternary species HSA-Ni-his.67
Conduding remarks
The increased coprecipitation of labelled nickel in the anti-IgG coprecipitation reaction provides additional and strong evidence for the presence of antibodies to nickel in patient SB with occupational asthma from nickel sensitivity. It may be concluded that the ligand competition studies, like the metal ion blocking experiments, clearly show that the formation of the reactive antigenic determinant depends on the selective binding of Ni2+ at the specific Cu2+/Ni2+ transport site of HSA. Corroborating evidence is derived from the similar dependence of pH of the Ni2+-HSA formation and the ammonium sulphate 63Ni2+ coprecipitation reactions. Presumably the strength of the Ni-HSAantibody interaction depends on a special structural feature of the interaction of Ni2+ with HSA. 
